Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging

Jeroen D C Goos1, Wiesje M van der Flier, Dirk L Knol

  • 1Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. j.goos@vumc.nl

Stroke
|May 14, 2011
PubMed
Abstract

Insights

Susceptibility-weighted imaging (SWI) detects more cerebral microbleeds (MBs) than gradient-recalled echo (GRE) imaging. However, this increased detection of MBs does not improve their clinical relevance regarding risk factors or markers of small-vessel disease.

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Susceptibility-weighted imaging (SWI) offers higher sensitivity for detecting cerebral microbleeds (MBs) compared to conventional T2*-weighted gradient-recalled echo (GRE) imaging.
  • The clinical significance of SWI's enhanced MB detection remains unclear.

Purpose of the Study:

  • To compare the associations of MBs with clinical characteristics, risk factors, white-matter hyperintensities, and lacunes using GRE versus SWI in memory clinic patients.
  • To determine if SWI improves the clinical relevance of MB detection.

Main Methods:

  • 141 memory clinic patients underwent clinical evaluation and MRI including GRE and SWI.
  • MBs and white-matter hyperintensities were quantified. Apolipoprotein E status was determined in a subset.
  • Negative binomial regression analyzed associations between MB number and clinical/radiologic factors.

Main Results:

  • MB prevalence was higher on SWI (40%) than GRE (23%).
  • SWI detected more MBs overall, with a higher median count in patients with MBs (P<0.001).
  • Associations between MB number and age, sex, white-matter hyperintensities, and lacunes were similar for both GRE and SWI.

Conclusions:

  • SWI enhances the detection of cerebral microbleeds in memory clinic patients.
  • Despite increased detection, SWI does not offer improved clinical relevance concerning vascular risk factors or markers of small-vessel disease.